- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 08.01. | Sanofi inks $400M biobucks deal to test the mettle of Alloy's antisense platform | ||
| 08.01. | Cassava lays off 3rd of workforce in wake of phase 3 Alzheimer's fail | ||
| 07.01. | Global CRO QPS makes Ryght choice for AI to automate clinical trials | ||
| 07.01. | FIRE1 heats up with $120M for its heart failure monitor implant | ||
| 07.01. | Stryker inks $4.9B deal for blood clot buster Inari Medical | ||
| 07.01. | AbbVie exercises first $40 million option to advance Capsida-partnered CNS gene therapy | ||
| 07.01. | Novo Nordisk and Variant set out to find new metabolic treatments, pay communities that share genetic data | ||
| 07.01. | Aviceda raises $207M series C to take geographic atrophy drug through phase 3 | ||
| 07.01. | Candid's T-cell engager shopping spree rolls on with WuXi Biologics pact worth up to $925M | ||
| 07.01. | Metsera links GLP-1 drug to 11% weight loss after 12 weeks, teeing up trial of monthly dosing | ||
| 07.01. | CytomX lays off 40% of staff, questions future of Amgen-partnered T-cell engager | ||
| 07.01. | Rival AbbVie and Denali prospects flunk phase 2/3 ALS tests, denting hopes for shared mechanism | ||
| 06.01. | Vertex pays Orna $65M to work on next-gen gene therapies for blood disorders | ||
| 06.01. | FDA draft guidance recommends tissue biopsies only be required in trials if necessary and low risk | ||
| 06.01. | Portage packages Tarus' adenosine receptor antagonists into new company with original leader | ||
| 06.01. | FDA issues draft guidance on ensuring pulse oximeter accuracy across skin tones | ||
| 06.01. | I-Mab pauses Sanofi-partnered prospect to make play for busy CLDN18.2 space | ||
| 06.01. | After Xeno's gastric-bypass alternative failed, LPOXY will test pill for C. diff infection | ||
| 06.01. | Oculis' peptidomimetic helps protect eyes from optic nerve inflammation in phase 2 | ||
| 03.01. | Basecamp Research pushes for programmable genetic medicines with new computer cluster, CSO and Massachusetts lab | ||
| 03.01. | Big Pharma layoff rounds jump 281% in '24, but overall industry rates similar to '23 | ||
| 03.01. | FDA completes first phase of study into potential metal exposure from tampons | ||
| 03.01. | Investor pumps $3M into cash-strapped Cyclacel in return for CEO role | ||
| 03.01. | Analysts predict M&A, IPO uptick in 2025 but don't expect 'floodgates to suddenly open' | ||
| 03.01. | iBio pens $29M biobucks deal with AstralBio for obesity med designed to preserve muscle mass |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
